HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gabriel N Hortobagyi Selected Research

Fluorouracil (Carac)

1/2014Outcomes of children exposed in utero to chemotherapy for breast cancer.
3/2012Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.
8/2011Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase.
1/2011Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.
11/2010Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.
6/2010Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines.
5/2010A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
3/2010A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer.
3/2010Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099.
1/2010Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Gabriel N Hortobagyi Research Topics

Disease

307Breast Neoplasms (Breast Cancer)
12/2015 - 01/2002
191Neoplasms (Cancer)
12/2015 - 01/2002
48Neoplasm Metastasis (Metastasis)
12/2015 - 06/2002
26Carcinoma (Carcinomatosis)
06/2007 - 05/2002
13Disease Progression
05/2013 - 04/2002
10Inflammatory Breast Neoplasms
01/2014 - 02/2004
9Residual Neoplasm
10/2015 - 04/2004
7Circulating Neoplastic Cells
11/2014 - 04/2009
7Neutropenia
05/2012 - 01/2003
5Noninfiltrating Intraductal Carcinoma (DCIS)
10/2014 - 06/2002
5Heart Failure
11/2013 - 11/2002
4Ovarian Neoplasms (Ovarian Cancer)
10/2014 - 11/2002
4Infection
05/2012 - 10/2002
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2011 - 10/2002
3Obesity
07/2014 - 09/2008
3Hypertension (High Blood Pressure)
11/2013 - 09/2007
3Male Breast Neoplasms (Male Breast Cancer)
05/2013 - 06/2002
3Hypersensitivity (Allergy)
01/2013 - 05/2002
3Pneumonia (Pneumonitis)
02/2012 - 07/2002
2Inflammation
07/2014 - 08/2007
2Coronary Artery Disease (Coronary Atherosclerosis)
11/2013 - 09/2007
2Peripheral Nervous System Diseases (PNS Diseases)
07/2013 - 11/2012
2Overweight
01/2013 - 01/2011
2Fatigue
02/2012 - 02/2004
2Anemia
02/2012 - 05/2009

Drug/Important Bio-Agent (IBA)

59HormonesIBA
04/2015 - 10/2002
58Estrogens (Estrogen)FDA Link
12/2015 - 01/2002
44Doxorubicin (Adriamycin)FDA LinkGeneric
11/2015 - 01/2002
40trastuzumab (Herceptin)FDA Link
07/2015 - 04/2002
40Epidermal Growth Factor Receptor (EGF Receptor)IBA
03/2015 - 10/2002
39Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2015 - 01/2002
35Paclitaxel (Taxol)FDA LinkGeneric
01/2015 - 05/2002
33Fluorouracil (Carac)FDA LinkGeneric
01/2014 - 01/2002
29taxaneIBA
01/2015 - 02/2002
21Progesterone Receptors (Progesterone Receptor)IBA
12/2015 - 10/2002
19docetaxel (Taxotere)FDA Link
04/2014 - 01/2002
17Phosphotransferases (Kinase)IBA
12/2015 - 05/2003
17Biological Markers (Surrogate Marker)IBA
01/2014 - 06/2002
15TaxoidsIBA
10/2015 - 05/2002
15TamoxifenFDA LinkGeneric
02/2012 - 01/2002
14DNA (Deoxyribonucleic Acid)IBA
12/2013 - 12/2006
13AnthracyclinesIBA
11/2015 - 09/2003
13everolimusFDA Link
03/2015 - 10/2007
12exemestane (Aromasin)FDA Link
03/2015 - 03/2004
12Aromatase (CYP19)IBA
03/2015 - 03/2004
10Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2014 - 06/2003
10Messenger RNA (mRNA)IBA
01/2013 - 06/2005
9capecitabine (Xeloda)FDA Link
03/2012 - 09/2003
8lapatinib (GW572016)FDA Link
07/2014 - 07/2008
8Proteins (Proteins, Gene)IBA
01/2013 - 09/2003
7Epirubicin (Ellence)FDA LinkGeneric
11/2015 - 06/2005
7Epidermal Growth Factor (EGF)IBA
10/2014 - 10/2007
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2012 - 08/2007
6DiphosphonatesIBA
04/2012 - 10/2003
6Transcription Factors (Transcription Factor)IBA
02/2012 - 09/2003
6bevacizumabFDA Link
08/2011 - 10/2004
5ixabepilone (BMS 247550)FDA Link
10/2015 - 08/2007
5Biological Tumor Markers (Tumor Markers)IBA
10/2014 - 10/2002
5ParaffinIBA
01/2013 - 04/2004
5anastrozole (Arimidex)FDA LinkGeneric
08/2012 - 06/2002
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2011 - 01/2002
5erlotinib (CP 358,774)FDA Link
01/2011 - 06/2007
5Estrogen ReceptorsIBA
12/2006 - 05/2002
4Protein Kinases (Protein Kinase)IBA
03/2015 - 02/2004
4Metformin (Glucophage)FDA LinkGeneric
07/2014 - 07/2009
4RNA (Ribonucleic Acid)IBA
02/2014 - 06/2003
4vinorelbine (Navelbine)FDA LinkGeneric
01/2014 - 01/2002
4Aromatase InhibitorsIBA
05/2013 - 02/2012
4Cyclin D1IBA
05/2010 - 10/2002
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2015 - 05/2005
3Sirolimus (Rapamycin)FDA Link
03/2015 - 02/2012
3Filgrastim (Neupogen)FDA Link
01/2014 - 07/2003
3CyclinsIBA
01/2013 - 10/2006
3zoledronic acid (zoledronate)FDA Link
04/2012 - 01/2005
3Selective Estrogen Receptor Modulators (SERM)IBA
02/2012 - 03/2004
3gemcitabineFDA Link
01/2011 - 05/2002
3Phenobarbital (Luminal)FDA Link
01/2011 - 08/2005
3CytotoxinsIBA
01/2011 - 05/2002
3Leucovorin (Folinic Acid)FDA Link
05/2010 - 06/2004
3thymidine 5'-triphosphate (TTP)IBA
05/2010 - 09/2004
3Cadherins (E-Cadherin)IBA
05/2010 - 12/2006
3Methotrexate (Mexate)FDA LinkGeneric
03/2010 - 11/2003
3tau Proteins (tau Protein)IBA
09/2009 - 06/2005
3Cyclin EIBA
01/2007 - 11/2002
2dasatinib (BMS 354825)FDA Link
10/2014 - 05/2010
2Formaldehyde (Formol)FDA Link
01/2013 - 05/2005
2triciribineIBA
09/2012 - 10/2007
2pamidronate (APD)FDA LinkGeneric
04/2012 - 06/2008

Therapy/Procedure

169Drug Therapy (Chemotherapy)
12/2015 - 01/2002
28Adjuvant Chemotherapy
03/2015 - 01/2002
20Radiotherapy
09/2011 - 06/2002
19Mastectomy (Mammectomy)
10/2014 - 01/2002
17Neoadjuvant Therapy
01/2015 - 10/2002
9Heterologous Transplantation (Xenotransplantation)
07/2014 - 10/2002
6Aftercare (After-Treatment)
12/2013 - 07/2002
4Segmental Mastectomy (Lumpectomy)
10/2009 - 07/2002
3Hematopoietic Stem Cell Transplantation
01/2012 - 11/2004
3Combination Drug Therapy (Combination Chemotherapy)
05/2011 - 02/2006
2Chemoprevention
02/2012 - 06/2002
2Therapeutics
01/2012 - 10/2004